These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2030355)

  • 1. Carcinomatous meningitis: antibody-guided therapy with I-131 HMFG1.
    Moseley RP; Benjamin JC; Ashpole RD; Sullivan NM; Bullimore JA; Coakham HB; Kemshead JT
    J Neurol Neurosurg Psychiatry; 1991 Mar; 54(3):260-5. PubMed ID: 2030355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral distribution of immunoconjugate after treatment for neoplastic meningitis using an intrathecal radiolabeled monoclonal antibody.
    Benjamin JC; Moss T; Moseley RP; Maxwell R; Coakham HB
    Neurosurgery; 1989 Aug; 25(2):253-8. PubMed ID: 2770989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMFG1 antigen: a new marker for carcinomatous meningitis.
    Moseley RP; Oge K; Shafqat S; Moseley CM; Sullivan NM; Badley RA; Burchell J; Taylor-Papadimitriou J; Coakham HB
    Int J Cancer; 1989 Sep; 44(3):440-4. PubMed ID: 2777410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments.
    Kalofonos HP; Sivolapenko GB; Courtenay-Luck NS; Snook DE; Hooker GR; Winter R; McKenzie CG; Taylor-Papadimitriou JJ; Lavender PJ; Epenetos AA
    Cancer Res; 1988 Apr; 48(7):1977-84. PubMed ID: 2832056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis.
    Moseley RP; Davies AG; Richardson RB; Zalutsky M; Carrell S; Fabre J; Slack N; Bullimore J; Pizer B; Papanastassiou V
    Br J Cancer; 1990 Oct; 62(4):637-42. PubMed ID: 2223581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results.
    Brown MT; Coleman RE; Friedman AH; Friedman HS; McLendon RE; Reiman R; Felsberg GJ; Tien RD; Bigner SH; Zalutsky MR; Zhao XG; Wikstrand CJ; Pegram CN; Herndon JE; Vick NA; Paleologos N; Fredericks RK; Schold SC; Bigner DD
    Clin Cancer Res; 1996 Jun; 2(6):963-72. PubMed ID: 9816257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalisation of an anti-EMA monoclonal antibody to a renal carcinoma xenograft.
    Yiu CY; Baker LA; Boulos PB
    Anticancer Res; 1990; 10(6):1775-8. PubMed ID: 2285258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoplastic meningitis in malignant melanoma: diagnosis with monoclonal antibodies.
    Moseley RP; Davies AG; Bourne SP; Popham C; Carrel S; Monro P; Coakham HB
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):881-6. PubMed ID: 2671265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma.
    Ferreira Filho AF; Cardoso F; Di Leo A; Awada A; da Silva VD; Tovar RB; Schwartsmann G
    Ann Oncol; 2001 Dec; 12(12):1757-9. PubMed ID: 11843255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of neoplastic meningitis by targeted radiation using (131)I-radiolabelled monoclonal antibodies. Results of responses and long term follow-up in 40 patients.
    Coakham HB; Kemshead JT
    J Neurooncol; 1998; 38(2-3):225-32. PubMed ID: 9696376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.
    Kaminski MS; Fig LM; Zasadny KR; Koral KF; DelRosario RB; Francis IR; Hanson CA; Normolle DP; Mudgett E; Liu CP
    J Clin Oncol; 1992 Nov; 10(11):1696-711. PubMed ID: 1403053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry of intrathecal iodine131 monoclonal antibody in cases of neoplastic meningitis.
    Richardson RB; Kemshead JT; Davies AG; Staddon GE; Jackson PC; Coakham HB; Lashford LS
    Eur J Nucl Med; 1990; 17(1-2):42-8. PubMed ID: 2083542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reshaping human monoclonal antibodies for imaging and therapy.
    Verhoeyen ME; Saunders JA; Broderick EL; Eida SJ; Badley RA
    Dis Markers; 1991; 9(3-4):197-203. PubMed ID: 1813210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-epithelial membrane antigen monoclonal antibodies and radioimmunolocalization of colorectal cancer.
    Yiu CY; Baker LA; Boulos PB
    Br J Surg; 1991 Oct; 78(10):1212-5. PubMed ID: 1958987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The present role of monoclonal antibodies in the diagnosis and therapy of brain tumours.
    Coakham HB; Kemshead JT
    Wien Klin Wochenschr; 1987 May; 99(11):372-8. PubMed ID: 3617765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of carcinoid meningitis: a challenge to the neurologist and oncologist].
    Rudnicka H; Niwińska A; Gruszfeld A; Pieńkowski T
    Neurol Neurochir Pol; 2003; 37(4):811-24. PubMed ID: 14746241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity, pharmacokinetics and bone marrow dosimetry of intrathecal radioimmunoconjugates.
    Moseley RP; Papanastassiou V; Zalutsky MR; Ashpole RD; Evans S; Bigner DD; Kemshead JT
    Int J Cancer; 1992 Aug; 52(1):38-43. PubMed ID: 1500225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential cytology of effusions using monoclonal antibodies].
    Lüttges J; Neumann K; Pflüger KH; Schmitz-Moormann P
    Pathologe; 1988 May; 9(3):137-42. PubMed ID: 2457213
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of intrathecal trastuzumab in a patient with carcinomatous meningitis.
    Laufman LR; Forsthoefel KF
    Clin Breast Cancer; 2001 Oct; 2(3):235. PubMed ID: 11899418
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report.
    Ashorn R; Ashorn P; Punnonen R; Pöyhönen L; Turjanmaa V; Koskinen M; Helle M; Uusitalo A; Pystynen P; Krohn K
    Ann Chir Gynaecol Suppl; 1985; 197():5-10. PubMed ID: 3863532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.